Get started
Author

Xiaorong Mao

Observed names: X R Mao, XIAO-RONG MAO, Xiao-Rong Mao, Xiao-rong Mao, Xiao‐Rong Mao
ORCID: 0000-0002-6072-679X
Observed ORCID: 0000-0002-6072-679X
OpenAlex ID: A5103125963
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
2025 · Jian Zhou, Li Bai, et al. · The Lancet Oncology · 77
Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
2018 · Li-Ting Zhang, Xue-Bin Peng, et al. · International Journal of Molecular Medicine · 30
PDF
Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study
2020 · Shuai Wang, Yifei Huang, et al. · The Lancet Regional Health - Western Pacific · 29
PDF
Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis
2019 · Aiping Tian, Ke Pu, et al. · Hepatology Research · 27
PDF
Development and validation of a radiomics signature as a non‐invasive complementary predictor of gastroesophageal varices and high‐risk varices in compensated advanced chronic liver disease: A multicenter study
2020 · Yifei Huang, Fangze Huang, et al. · Journal of Gastroenterology and Hepatology · 24
Efficacy and safety of GLS4/ritonavir combined with entecavir in HBeAg-positive patients with chronic hepatitis B: interim results from phase 2b, multi-center study
2020 · Mingyuan Zhang, Jiming Zhang, et al. · Journal of Hepatology · 24
Whole‐Liver Apparent Diffusion Coefficient Histogram Analysis for the Diagnosis and Staging of Liver Fibrosis
2019 · You Zheng, Yong‐Sheng Xu, et al. · Journal of Magnetic Resonance Imaging · 23
Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients
2014 · XIAO-RONG MAO, LI-TING ZHANG, et al. · Experimental and Therapeutic Medicine · 22
PDF
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study
2025 · Yameng Sun, Cuisong Wu, et al. · Hepatology · 20
Unravelling the Role of PANoptosis in Liver Diseases: Mechanisms and Therapeutic Implications
2025 · Wanyuan Xiong, Junfeng Li, et al. · Liver International · 20
Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
2020 · Li-Ting Yan, Li-Li Wang, et al. · Medicine · 20
Inhibitors of PARP-1 exert inhibitory effects on the biological characteristics of hepatocellular carcinoma cells in vitro
2017 · Xiaorong Mao, Senrong Du, et al. · Molecular Medicine Reports · 18
PDF
Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway
2015 · LI-TING ZHANG, XUE-QIN FANG, et al. · Molecular Medicine Reports · 17
PDF
Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial
2025 · Junqi Niu, Yanhang Gao, et al. · Gut · 16
Ferritinophagy: A new idea for liver diseases regulated by ferroptosis
2023 · Zi-Bing Qian, Jun-Feng Li, et al. · Hepatobiliary & pancreatic diseases international · 15
A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C
2022 · Chi‐Yi Chen, Wan‐Long Chuang, et al. · JGH Open · 14
PDF
Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies
2021 · Xuebin Peng, Aiping Tian, et al. · Digestive Diseases and Sciences · 14
Annexin A: Cell Death, Inflammation, and Translational Medicine
2025 · Zibing Qian, Ziyi Li, et al. · Journal of Inflammation Research · 13
PDF
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial
2025 · Mingyuan Zhang, Yanhang Gao, et al. · Journal of Infection · 12
PDF
Knockout of UBE2S inhibits the proliferation of gastric cancer cells and induces apoptosis by FAS-mediated death receptor pathway
2022 · Rongrong Zhao, Zeyuan Yu, et al. · Experimental Cell Research · 11
Macrophage Perspectives in Liver Diseases: Programmed Death, Related Biomarkers, and Targeted Therapy
2024 · Zibing Qian, Wanyuan Xiong, et al. · Biomolecules · 9
Predictors of portal vein thrombosis after splenectomy in patients with cirrhosis
2024 · Ting Li, Li-Li Wang, et al. · World Journal of Hepatology · 9
Naringin from Ganshuang granule inhibits inflammatory to relieve liver fibrosis through TGF-β-Smad signaling pathway
2024 · Fuchun Wang, Jian Gan, et al. · PLoS ONE · 8
Peginterferon α-2b Enhances Hepatitis B Surface Antigen Loss in Nucleos(t)ide Analogue-Suppressed Low Hepatitis B Surface Antigen Chronic Hepatitis B Patients: Everest Study in China
2026 · Chan Xie, Bingliang Lin, et al. · Clinical Gastroenterology and Hepatology · 7
PDF
A Novel Deep Learning Framework for Liver Fibrosis Staging and Etiology Diagnosis Using Integrated Liver–Spleen Elastography
2025 · Kai Yang, Fei Chen, et al. · Diagnostics · 6
PDF
Works count: 64
Citation count: 560
H-index: 15
I10-index: 20
Year
Topic
Type